Clinical Trial Update: A Study to Investigate the Cardiovascular Safety of Apricitabine in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the cardiovascular safety of Apricitabine in healthy volunteers; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Apricitabine (Apricitabine)

Snippet

Sponsor: Avexa | Conditions: HIV Infections | Phase 1 | Status: COMPLETED